In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization ...

Managing mucus from COPD involves strategies that can help loosen mucus and clear it from your airway, such as staying ...

Study finds adults consuming more sugary drinks have higher odds of COPD, highlighting links between diet and lung health.

U.S. adults faced a greater likelihood for COPD if their daily sugar caloric intake from sugar-sweetened beverages was 10% or ...

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...

FLAME analysis suggests COPD exacerbation risk spikes for 3 months after stopping LAMA or ICS, underscoring adherence and careful step-down.

Quitting smoking and avoiding vaping may be crucial steps in managing COPD, as these habits expose your lungs to irritants that cause further damage. Quitting may slow the disease’s progression and ...

Indoor and outdoor pollutants and climate extremes have shown association with COPD exacerbations separately, but these factors also can act synergistically to increase morbidity in patients with high ...

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An injectable interleukin ...

GSK's Nucala (mepolizumab) has received European Commission approval as an add on maintenance treatment for uncontrolled COPD. The approval is supported by positive Phase III MATINEE trial results.

GSK (GSK) stock is in focus as the company wins EU approval to expand its Nucala asthma drug into chronic obstructive ...